Literature DB >> 9305492

Mucosal interleukin-1 beta production and acid secretion in enlarged fold gastritis.

Y Yasunaga1, Y Shinomura, S Kanayama, Y Higashimoto, M Yabu, Y Miyazaki, Y Murayama, H Nishibayashi, S Kitamura, Y Matsuzawa.   

Abstract

BACKGROUND: We have previously shown that eradication of Helicobacter pylori increases acid secretion in H. pylori-associated enlarged fold gastritis. AIM: To investigate whether locally produced interleukin-1 beta is possibly involved in the inhibition of acid secretion in H. pylori gastritis.
METHODS: IL-1 beta release from the gastric body mucosa was determined by short-term culture of biopsy specimens in 13 patients with enlarged fold gastritis (all H. pylori-positive), five H. pylori-positive and 10 H. pylori-negative patients without enlarged folds. The acid-inhibitory effect of locally produced IL-1 beta was examined by [14C]-aminopyrine uptake assay using isolated rabbit gastric glands.
RESULTS: IL-1 beta release was significantly greater in patients with enlarged fold gastritis, significantly correlated with both basal and tetragastrin-stimulated acid outputs in the H. pylori-positive patients (r = -0.591 and r = -0.641, respectively; P < 0.01), and significantly decreased with concomitant increases in acid secretions after eradication of H. pylori. [14C]-aminopyrine uptake was inhibited by IL-1 beta in a dose-dependent manner.
CONCLUSIONS: Increased production of IL-1 beta caused by H. pylori infection is possibly involved in the inhibition of acid secretion in enlarged fold gastritis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9305492     DOI: 10.1046/j.1365-2036.1997.00200.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  6 in total

1.  Inhibition of carbachol stimulated acid secretion by interleukin 1beta in rabbit parietal cells requires protein kinase C.

Authors:  I L Beales; J Calam
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

Review 2.  Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses.

Authors:  Holly M Scott Algood; Timothy L Cover
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

3.  Relation between clinical presentation, Helicobacter pylori density, interleukin 1beta and 8 production, and cagA status.

Authors:  Y Yamaoka; T Kodama; M Kita; J Imanishi; K Kashima; D Y Graham
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

4.  Role of gastric acid secretion in the pathogenesis of Barrett's esophageal cancer in a Japanese population.

Authors:  Tomoyuki Koike; Shuichi Ohara; Tooru Shimosegawa
Journal:  Clin J Gastroenterol       Date:  2009-05-02

5.  Treatment of Helicobacter gastritis with IL-4 requires somatostatin.

Authors:  Yana Zavros; Sivaprakash Rathinavelu; John Y Kao; Andrea Todisco; John Del Valle; Joel V Weinstock; Malcolm J Low; Juanita L Merchant
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-10       Impact factor: 11.205

Review 6.  Endoscopic Kyoto classification of Helicobacter pylori infection and gastric cancer risk diagnosis.

Authors:  Osamu Toyoshima; Toshihiro Nishizawa; Kazuhiko Koike
Journal:  World J Gastroenterol       Date:  2020-02-07       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.